Can a special unit for the treatment of tetanus be justified in a developing country?
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002697:Chloral Hydrate / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003906:Developing Countries; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007362:Intensive Care Units; D007630:Kenya; D008297:Male; D008875:Middle Aged; D010242:Paraldehyde / Q000627:therapeutic use; D013742:Tetanus / Q000401:mortality / Q000628:therapy*
D002697:Chloral Hydrate; D003975:Diazepam; D010242:Paraldehyde; D002746:Chlorpromazine